10 BioMarin regulatory affairs leaders
Elizabeth Moyle, Vice President Regulatory Affairs, leads this list of BioMarin regulatory affairs leaders, who hold current titles in global regulatory affairs CMC, clinical and nonclinical regulatory work and US regulatory policy. A reader can learn how regulatory affairs leaders work at BioMarin from people who have held the role.
Professionals to explore
Elizabeth Bradley, MS, PharmD
LinkedInExperience: Senior Director Regulatory Affairs · BioMarin Pharmaceutical Inc.
Elizabeth Bradley has been Senior Director Regulatory Affairs at BioMarin Pharmaceutical Inc. since March 2025, based in the New York City Metropolitan Area. At BioMarin, Elizabeth Bradley was Director Regulatory Affairs from 2023 to 2025 and Associate Director Regulatory Affairs from 2022 to 2023, and was Senior Manager Regulatory Affairs at Regeneron from 2021 to 2022.
Elizabeth Moyle
LinkedInExperience: Vice President Regulatory Affairs · BioMarin Pharmaceutical Inc.
Elizabeth Moyle has been Vice President Regulatory Affairs at BioMarin Pharmaceutical Inc. since March 2022, based in Oakland, California. Elizabeth Moyle was Executive Director, Regulatory Global Labeling at BioMarin from 2019 to 2022 and GRA CMC Associate Director at Bayer from 2009 to 2012.
Hayley Pemble
LinkedInExperience: Senior Director, Regulatory Affairs · BioMarin Pharmaceutical Inc.
Hayley Pemble has been Senior Director, Regulatory Affairs at BioMarin Pharmaceutical Inc. since March 2024, based in San Francisco. The listing also shows Hayley Pemble as Director of Regulatory Affairs at BioMarin since October 2014 and as a Regulatory Affairs Intern there in 2014.
Helen Takanabe
LinkedInExperience: Senior Director of Global Regulatory Affairs, CMC · BioMarin Pharmaceutical Inc.
Helen Takanabe has been Senior Director of Global Regulatory Affairs, CMC at BioMarin Pharmaceutical Inc. since March 2025, based in the Los Angeles Metropolitan Area. Helen Takanabe held Director of Global Regulatory Affairs, CMC at BioMarin from 2022 to 2025 and was Sr. Manager Regulatory Affairs at Amgen from 2015 to 2022.
Jewell Martin, MA, MBA, PMP, RAC
LinkedInExperience: Director, US Regulatory Policy · BioMarin Pharmaceutical Inc.
Jewell Martin has been Director, US Regulatory Policy at BioMarin Pharmaceutical Inc. since September 2023, based in Silver Spring, Maryland. Jewell Martin was Associate Director at BioMarin from 2020 to 2023 and Staff Director at FDA from 2019 to 2020.
Jocelyn Oriondo
LinkedInExperience: Senior Director Regulatory Affairs · BioMarin Pharmaceutical Inc.
Jocelyn Oriondo has been Senior Director Regulatory Affairs at BioMarin Pharmaceutical Inc. since August 2020, based in the United States. Jocelyn Oriondo was Director, Regulatory Affairs at BioMarin from 2018 to 2020 and Director Regulatory Affairs at Amgen from 2016 to 2017.
Laura Buffa
LinkedInExperience: Director - Regulatory Affairs CMC · BioMarin Pharmaceutical Inc.
Laura Buffa has been Director - Regulatory Affairs CMC at BioMarin Pharmaceutical Inc. since March 2026, based in Thousand Oaks, California. At BioMarin, Laura Buffa was Associate Director - Regulatory Affairs CMC from 2024 to 2026 and Sr Manager - Regulatory Affairs CMC from 2022 to 2024, and was Manager - Medical Devices Regulatory Affairs at Amgen from 2020 to 2022.
Matt Gray
LinkedInExperience: Senior Director, Regulatory Affairs Clinical Non-Clinical · BioMarin Pharmaceutical Inc.
Matt Gray has been Senior Director, Regulatory Affairs Clinical Non-Clinical at BioMarin Pharmaceutical Inc. since October 2021, based in the San Francisco Bay Area. At BioMarin, Matt Gray was Senior Director, Regulatory Affairs CMC from 2019 to 2021, Director, Regulatory Affairs CMC from 2016 to 2019 and Director, Quality Assurance Systems from 2012 to 2015.
Michelle Fong
LinkedInExperience: Senior Director, Regulatory Affairs · BioMarin Pharmaceutical Inc.
Michelle Fong has held the Senior Director, Regulatory Affairs title at BioMarin Pharmaceutical Inc. since January 2006, the only role shown in the listing, and is based in the San Francisco Bay Area. The profile headline and summary both read Executive Director, Regulatory Affairs at BioMarin.
Parvin Perrino
LinkedInExperience: Senior Director, Regulatory Affairs Clinical Nonclinical Global Regulatory Lead · BioMarin Pharmaceutical Inc.
Parvin Perrino has been Senior Director, Regulatory Affairs Clinical Nonclinical Global Regulatory Lead at BioMarin Pharmaceutical Inc. since August 2022, based in the San Francisco Bay Area. At BioMarin, Parvin Perrino also held Senior Director, Regulatory Affairs Labeling from 2020 to 2023 and Director, Regulatory Affairs Labeling from 2017 to 2020.
Choose the right perspective
Pick the person whose title is closest to your question, whether that is CMC, clinical and nonclinical strategy or regulatory policy. Consider whether you need someone who sets direction for the function or a director who runs one area of regulatory work day to day.
Questions to take into the conversation
- 01What did you focus on first when you took on your regulatory affairs role at BioMarin?
- 02How has your approach to regulatory work changed as your scope grew?
- 03What has your own work at BioMarin taught you about developing regulatory affairs staff?
Reaching BioMarin regulatory affairs leaders
How can I contact one of these BioMarin regulatory affairs leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: BioMarin Pharmaceutical Inc., based on profile data retrieved on October 25, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach BioMarin regulatory affairs leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these BioMarin regulatory affairs leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.